NCT03978351UnknownNot Applicable
The Role of Midkine in Diagnosis of Thyroid Cancer
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Assiut University
- Enrollment
- 85
- Primary Endpoint
- serum midkine levels
Study Overview
Brief Summary
- Evaluation of the role of serum midkine in differentiating malignant from benign thyroid nodule
- studying the level of serum midkine in relation to different thyroid cancer stages
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •patient with thyroid nodule
Exclusion Criteria
- •Other known organ tumour
- •Chemothyrapy
- •Radiothyrapy c. Sample Size Calculation
Outcomes
Primary Outcomes
serum midkine levels
Time Frame: Baseline
Secondary Outcomes
No secondary outcomes reported
Investigators
Marwa Hassan Thabet Ahmed
Principal investigator
Assiut University
Similar Trials
Completed
Not Applicable
A New Diagnostic Method for Thyroid Carcinoma Associated with Autoantibody against Cancer Specific AntigeThyroid CarcinomaJPRN-UMIN000029164Tottori University Hospital180
Not yet recruiting
Not Applicable
Detection of thyroid cancer and central lymph node metastases using bevacizumab-IRDye800CW enhanced Molecular Fluorescence Guided Surgery1004373910014713thyroid cancerNL-OMON51075niversitair Medisch Centrum Groningen32
Unknown
Not Applicable
Evaluation of Thymidine Kinase Activity in the Serum of Patients With Solid TumorsSolid TumorsNCT01050413Hadassah Medical Organization300
Unknown
Not Applicable
Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid CancerThyroid CancerNCT03469544Assiut University90
Completed
Not Applicable
microRNA in Thyroid CancerFNAmicroRNAThyroid CancerThyroid NoduleNCT01964508Hadassah Medical Organization77